mavii

Abbott Laboratories (NYSE:ABT) is set to report its first-quarter earnings results on Wednesday, April 16th, before the market opens. Wall Street expects modest year-over-year growth, with analysts forecasting EPS of $1.

Abbott Laboratories reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. The U.S. MedTech giant reported adjusted EPS of $1.09, beating the consensus of $1.07 and the management guidance of $1.05-$1.09.